nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—migraine—Prednisone—atopic dermatitis	0.473	1	CpDpCtD
Eletriptan—PTGS1—Diphenhydramine—atopic dermatitis	0.0366	0.103	CbGbCtD
Eletriptan—CYP2A6—Prednisolone—atopic dermatitis	0.0252	0.0708	CbGbCtD
Eletriptan—CYP3A4—Pimecrolimus—atopic dermatitis	0.0197	0.0554	CbGbCtD
Eletriptan—ABCB1—Tacrolimus—atopic dermatitis	0.0195	0.055	CbGbCtD
Eletriptan—CYP2C19—Loratadine—atopic dermatitis	0.0177	0.0499	CbGbCtD
Eletriptan—CYP2C19—Diphenhydramine—atopic dermatitis	0.0177	0.0499	CbGbCtD
Eletriptan—CYP2A6—Dexamethasone—atopic dermatitis	0.0148	0.0417	CbGbCtD
Eletriptan—CYP2C9—Loratadine—atopic dermatitis	0.0147	0.0415	CbGbCtD
Eletriptan—CYP2C9—Diphenhydramine—atopic dermatitis	0.0147	0.0415	CbGbCtD
Eletriptan—ABCB1—Loratadine—atopic dermatitis	0.0143	0.0403	CbGbCtD
Eletriptan—CYP2D6—Loratadine—atopic dermatitis	0.0135	0.0379	CbGbCtD
Eletriptan—CYP2D6—Diphenhydramine—atopic dermatitis	0.0135	0.0379	CbGbCtD
Eletriptan—ABCB1—Methylprednisolone—atopic dermatitis	0.0131	0.0368	CbGbCtD
Eletriptan—CYP3A4—Tacrolimus—atopic dermatitis	0.0117	0.033	CbGbCtD
Eletriptan—CYP2C19—Prednisone—atopic dermatitis	0.00982	0.0277	CbGbCtD
Eletriptan—CYP3A4—Loratadine—atopic dermatitis	0.00857	0.0241	CbGbCtD
Eletriptan—ABCB1—Betamethasone—atopic dermatitis	0.00851	0.0239	CbGbCtD
Eletriptan—ABCB1—Prednisolone—atopic dermatitis	0.00839	0.0236	CbGbCtD
Eletriptan—ABCB1—Hydrocortisone—atopic dermatitis	0.00796	0.0224	CbGbCtD
Eletriptan—ABCB1—Prednisone—atopic dermatitis	0.00793	0.0223	CbGbCtD
Eletriptan—CYP3A4—Methylprednisolone—atopic dermatitis	0.00784	0.0221	CbGbCtD
Eletriptan—CYP2C19—Dexamethasone—atopic dermatitis	0.00613	0.0173	CbGbCtD
Eletriptan—CYP3A4—Triamcinolone—atopic dermatitis	0.00594	0.0167	CbGbCtD
Eletriptan—CYP2C9—Dexamethasone—atopic dermatitis	0.0051	0.0144	CbGbCtD
Eletriptan—CYP3A4—Betamethasone—atopic dermatitis	0.0051	0.0143	CbGbCtD
Eletriptan—CYP3A4—Prednisolone—atopic dermatitis	0.00503	0.0142	CbGbCtD
Eletriptan—ABCB1—Dexamethasone—atopic dermatitis	0.00495	0.0139	CbGbCtD
Eletriptan—CYP3A4—Hydrocortisone—atopic dermatitis	0.00477	0.0134	CbGbCtD
Eletriptan—CYP3A4—Prednisone—atopic dermatitis	0.00475	0.0134	CbGbCtD
Eletriptan—CYP2D6—Dexamethasone—atopic dermatitis	0.00466	0.0131	CbGbCtD
Eletriptan—CYP3A4—Dexamethasone—atopic dermatitis	0.00297	0.00835	CbGbCtD
Eletriptan—Malaise—Methylprednisolone—atopic dermatitis	6.68e-05	0.000468	CcSEcCtD
Eletriptan—Vertigo—Triamcinolone—atopic dermatitis	6.67e-05	0.000468	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	6.67e-05	0.000467	CcSEcCtD
Eletriptan—Syncope—Triamcinolone—atopic dermatitis	6.66e-05	0.000467	CcSEcCtD
Eletriptan—Vertigo—Methylprednisolone—atopic dermatitis	6.66e-05	0.000466	CcSEcCtD
Eletriptan—Syncope—Methylprednisolone—atopic dermatitis	6.64e-05	0.000466	CcSEcCtD
Eletriptan—Discomfort—Hydrocortisone—atopic dermatitis	6.63e-05	0.000465	CcSEcCtD
Eletriptan—Oedema—Prednisolone—atopic dermatitis	6.59e-05	0.000462	CcSEcCtD
Eletriptan—Vomiting—Tacrolimus—atopic dermatitis	6.56e-05	0.00046	CcSEcCtD
Eletriptan—Loss of consciousness—Triamcinolone—atopic dermatitis	6.53e-05	0.000457	CcSEcCtD
Eletriptan—Loss of consciousness—Methylprednisolone—atopic dermatitis	6.51e-05	0.000456	CcSEcCtD
Eletriptan—Rash—Tacrolimus—atopic dermatitis	6.51e-05	0.000456	CcSEcCtD
Eletriptan—Dermatitis—Tacrolimus—atopic dermatitis	6.5e-05	0.000455	CcSEcCtD
Eletriptan—Shock—Prednisolone—atopic dermatitis	6.48e-05	0.000454	CcSEcCtD
Eletriptan—Cough—Triamcinolone—atopic dermatitis	6.48e-05	0.000454	CcSEcCtD
Eletriptan—Headache—Tacrolimus—atopic dermatitis	6.46e-05	0.000453	CcSEcCtD
Eletriptan—Oedema—Hydrocortisone—atopic dermatitis	6.44e-05	0.000451	CcSEcCtD
Eletriptan—Convulsion—Triamcinolone—atopic dermatitis	6.43e-05	0.000451	CcSEcCtD
Eletriptan—Tachycardia—Prednisolone—atopic dermatitis	6.43e-05	0.000451	CcSEcCtD
Eletriptan—Convulsion—Methylprednisolone—atopic dermatitis	6.42e-05	0.00045	CcSEcCtD
Eletriptan—Hypertension—Triamcinolone—atopic dermatitis	6.41e-05	0.000449	CcSEcCtD
Eletriptan—Hypertension—Methylprednisolone—atopic dermatitis	6.4e-05	0.000448	CcSEcCtD
Eletriptan—Hyperhidrosis—Prednisolone—atopic dermatitis	6.37e-05	0.000446	CcSEcCtD
Eletriptan—Shock—Hydrocortisone—atopic dermatitis	6.33e-05	0.000444	CcSEcCtD
Eletriptan—Myalgia—Triamcinolone—atopic dermatitis	6.32e-05	0.000443	CcSEcCtD
Eletriptan—Nervous system disorder—Hydrocortisone—atopic dermatitis	6.31e-05	0.000442	CcSEcCtD
Eletriptan—Arthralgia—Methylprednisolone—atopic dermatitis	6.31e-05	0.000442	CcSEcCtD
Eletriptan—Myalgia—Methylprednisolone—atopic dermatitis	6.31e-05	0.000442	CcSEcCtD
Eletriptan—Anxiety—Methylprednisolone—atopic dermatitis	6.29e-05	0.00044	CcSEcCtD
Eletriptan—Tachycardia—Hydrocortisone—atopic dermatitis	6.28e-05	0.00044	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	6.26e-05	0.000439	CcSEcCtD
Eletriptan—Flushing—Prednisone—atopic dermatitis	6.26e-05	0.000438	CcSEcCtD
Eletriptan—Skin disorder—Hydrocortisone—atopic dermatitis	6.25e-05	0.000438	CcSEcCtD
Eletriptan—Ill-defined disorder—Dexamethasone—atopic dermatitis	6.25e-05	0.000438	CcSEcCtD
Eletriptan—Ill-defined disorder—Betamethasone—atopic dermatitis	6.25e-05	0.000438	CcSEcCtD
Eletriptan—Discomfort—Triamcinolone—atopic dermatitis	6.25e-05	0.000438	CcSEcCtD
Eletriptan—Discomfort—Methylprednisolone—atopic dermatitis	6.23e-05	0.000437	CcSEcCtD
Eletriptan—Hyperhidrosis—Hydrocortisone—atopic dermatitis	6.22e-05	0.000436	CcSEcCtD
Eletriptan—Dry mouth—Triamcinolone—atopic dermatitis	6.18e-05	0.000433	CcSEcCtD
Eletriptan—Angioedema—Dexamethasone—atopic dermatitis	6.16e-05	0.000431	CcSEcCtD
Eletriptan—Angioedema—Betamethasone—atopic dermatitis	6.16e-05	0.000431	CcSEcCtD
Eletriptan—Anorexia—Hydrocortisone—atopic dermatitis	6.14e-05	0.00043	CcSEcCtD
Eletriptan—Nausea—Tacrolimus—atopic dermatitis	6.13e-05	0.000429	CcSEcCtD
Eletriptan—Confusional state—Methylprednisolone—atopic dermatitis	6.1e-05	0.000427	CcSEcCtD
Eletriptan—Immune system disorder—Prednisone—atopic dermatitis	6.09e-05	0.000427	CcSEcCtD
Eletriptan—Malaise—Dexamethasone—atopic dermatitis	6.08e-05	0.000426	CcSEcCtD
Eletriptan—Malaise—Betamethasone—atopic dermatitis	6.08e-05	0.000426	CcSEcCtD
Eletriptan—Oedema—Triamcinolone—atopic dermatitis	6.06e-05	0.000425	CcSEcCtD
Eletriptan—Vertigo—Dexamethasone—atopic dermatitis	6.05e-05	0.000424	CcSEcCtD
Eletriptan—Vertigo—Betamethasone—atopic dermatitis	6.05e-05	0.000424	CcSEcCtD
Eletriptan—Syncope—Dexamethasone—atopic dermatitis	6.04e-05	0.000423	CcSEcCtD
Eletriptan—Syncope—Betamethasone—atopic dermatitis	6.04e-05	0.000423	CcSEcCtD
Eletriptan—Arrhythmia—Prednisone—atopic dermatitis	6.02e-05	0.000422	CcSEcCtD
Eletriptan—Hypotension—Hydrocortisone—atopic dermatitis	6.01e-05	0.000421	CcSEcCtD
Eletriptan—Shock—Triamcinolone—atopic dermatitis	5.96e-05	0.000418	CcSEcCtD
Eletriptan—Insomnia—Prednisolone—atopic dermatitis	5.96e-05	0.000418	CcSEcCtD
Eletriptan—Alopecia—Prednisone—atopic dermatitis	5.96e-05	0.000417	CcSEcCtD
Eletriptan—Shock—Methylprednisolone—atopic dermatitis	5.95e-05	0.000417	CcSEcCtD
Eletriptan—Nervous system disorder—Methylprednisolone—atopic dermatitis	5.93e-05	0.000416	CcSEcCtD
Eletriptan—Loss of consciousness—Dexamethasone—atopic dermatitis	5.92e-05	0.000415	CcSEcCtD
Eletriptan—Loss of consciousness—Betamethasone—atopic dermatitis	5.92e-05	0.000415	CcSEcCtD
Eletriptan—Paraesthesia—Prednisolone—atopic dermatitis	5.92e-05	0.000415	CcSEcCtD
Eletriptan—Tachycardia—Triamcinolone—atopic dermatitis	5.91e-05	0.000414	CcSEcCtD
Eletriptan—Tachycardia—Methylprednisolone—atopic dermatitis	5.9e-05	0.000414	CcSEcCtD
Eletriptan—Skin disorder—Methylprednisolone—atopic dermatitis	5.87e-05	0.000412	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	5.86e-05	0.000411	CcSEcCtD
Eletriptan—Hyperhidrosis—Triamcinolone—atopic dermatitis	5.86e-05	0.000411	CcSEcCtD
Eletriptan—Hyperhidrosis—Methylprednisolone—atopic dermatitis	5.85e-05	0.00041	CcSEcCtD
Eletriptan—Convulsion—Betamethasone—atopic dermatitis	5.84e-05	0.000409	CcSEcCtD
Eletriptan—Convulsion—Dexamethasone—atopic dermatitis	5.84e-05	0.000409	CcSEcCtD
Eletriptan—Insomnia—Hydrocortisone—atopic dermatitis	5.82e-05	0.000408	CcSEcCtD
Eletriptan—Hypertension—Betamethasone—atopic dermatitis	5.82e-05	0.000408	CcSEcCtD
Eletriptan—Hypertension—Dexamethasone—atopic dermatitis	5.82e-05	0.000408	CcSEcCtD
Eletriptan—Paraesthesia—Hydrocortisone—atopic dermatitis	5.78e-05	0.000405	CcSEcCtD
Eletriptan—Myalgia—Dexamethasone—atopic dermatitis	5.74e-05	0.000402	CcSEcCtD
Eletriptan—Myalgia—Betamethasone—atopic dermatitis	5.74e-05	0.000402	CcSEcCtD
Eletriptan—Anxiety—Dexamethasone—atopic dermatitis	5.72e-05	0.000401	CcSEcCtD
Eletriptan—Anxiety—Betamethasone—atopic dermatitis	5.72e-05	0.000401	CcSEcCtD
Eletriptan—Discomfort—Betamethasone—atopic dermatitis	5.67e-05	0.000397	CcSEcCtD
Eletriptan—Discomfort—Dexamethasone—atopic dermatitis	5.67e-05	0.000397	CcSEcCtD
Eletriptan—Dyspepsia—Hydrocortisone—atopic dermatitis	5.67e-05	0.000397	CcSEcCtD
Eletriptan—Hypotension—Methylprednisolone—atopic dermatitis	5.65e-05	0.000396	CcSEcCtD
Eletriptan—Pain—Prednisolone—atopic dermatitis	5.64e-05	0.000395	CcSEcCtD
Eletriptan—Decreased appetite—Hydrocortisone—atopic dermatitis	5.59e-05	0.000392	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	5.56e-05	0.000389	CcSEcCtD
Eletriptan—Fatigue—Hydrocortisone—atopic dermatitis	5.55e-05	0.000389	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	5.52e-05	0.000387	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	5.51e-05	0.000386	CcSEcCtD
Eletriptan—Pain—Hydrocortisone—atopic dermatitis	5.5e-05	0.000386	CcSEcCtD
Eletriptan—Oedema—Dexamethasone—atopic dermatitis	5.5e-05	0.000385	CcSEcCtD
Eletriptan—Oedema—Betamethasone—atopic dermatitis	5.5e-05	0.000385	CcSEcCtD
Eletriptan—Insomnia—Triamcinolone—atopic dermatitis	5.48e-05	0.000384	CcSEcCtD
Eletriptan—Insomnia—Methylprednisolone—atopic dermatitis	5.47e-05	0.000383	CcSEcCtD
Eletriptan—Ill-defined disorder—Prednisone—atopic dermatitis	5.44e-05	0.000381	CcSEcCtD
Eletriptan—Paraesthesia—Triamcinolone—atopic dermatitis	5.44e-05	0.000381	CcSEcCtD
Eletriptan—Feeling abnormal—Prednisolone—atopic dermatitis	5.43e-05	0.000381	CcSEcCtD
Eletriptan—Paraesthesia—Methylprednisolone—atopic dermatitis	5.43e-05	0.00038	CcSEcCtD
Eletriptan—Anaemia—Prednisone—atopic dermatitis	5.42e-05	0.00038	CcSEcCtD
Eletriptan—Shock—Dexamethasone—atopic dermatitis	5.41e-05	0.000379	CcSEcCtD
Eletriptan—Shock—Betamethasone—atopic dermatitis	5.41e-05	0.000379	CcSEcCtD
Eletriptan—Dyspnoea—Triamcinolone—atopic dermatitis	5.4e-05	0.000379	CcSEcCtD
Eletriptan—Nervous system disorder—Dexamethasone—atopic dermatitis	5.39e-05	0.000378	CcSEcCtD
Eletriptan—Nervous system disorder—Betamethasone—atopic dermatitis	5.39e-05	0.000378	CcSEcCtD
Eletriptan—Agitation—Prednisone—atopic dermatitis	5.39e-05	0.000378	CcSEcCtD
Eletriptan—Tachycardia—Betamethasone—atopic dermatitis	5.37e-05	0.000376	CcSEcCtD
Eletriptan—Tachycardia—Dexamethasone—atopic dermatitis	5.37e-05	0.000376	CcSEcCtD
Eletriptan—Angioedema—Prednisone—atopic dermatitis	5.36e-05	0.000376	CcSEcCtD
Eletriptan—Dyspepsia—Triamcinolone—atopic dermatitis	5.33e-05	0.000374	CcSEcCtD
Eletriptan—Dyspepsia—Methylprednisolone—atopic dermatitis	5.32e-05	0.000373	CcSEcCtD
Eletriptan—Hyperhidrosis—Betamethasone—atopic dermatitis	5.32e-05	0.000373	CcSEcCtD
Eletriptan—Hyperhidrosis—Dexamethasone—atopic dermatitis	5.32e-05	0.000373	CcSEcCtD
Eletriptan—Feeling abnormal—Hydrocortisone—atopic dermatitis	5.3e-05	0.000372	CcSEcCtD
Eletriptan—Malaise—Prednisone—atopic dermatitis	5.29e-05	0.000371	CcSEcCtD
Eletriptan—Vertigo—Prednisone—atopic dermatitis	5.27e-05	0.000369	CcSEcCtD
Eletriptan—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	5.26e-05	0.000369	CcSEcCtD
Eletriptan—Syncope—Prednisone—atopic dermatitis	5.26e-05	0.000369	CcSEcCtD
Eletriptan—Anorexia—Betamethasone—atopic dermatitis	5.24e-05	0.000367	CcSEcCtD
Eletriptan—Anorexia—Dexamethasone—atopic dermatitis	5.24e-05	0.000367	CcSEcCtD
Eletriptan—Urticaria—Prednisolone—atopic dermatitis	5.24e-05	0.000367	CcSEcCtD
Eletriptan—Fatigue—Triamcinolone—atopic dermatitis	5.22e-05	0.000366	CcSEcCtD
Eletriptan—Fatigue—Methylprednisolone—atopic dermatitis	5.21e-05	0.000365	CcSEcCtD
Eletriptan—Pain—Triamcinolone—atopic dermatitis	5.18e-05	0.000363	CcSEcCtD
Eletriptan—Loss of consciousness—Prednisone—atopic dermatitis	5.16e-05	0.000361	CcSEcCtD
Eletriptan—Hypotension—Betamethasone—atopic dermatitis	5.14e-05	0.00036	CcSEcCtD
Eletriptan—Hypotension—Dexamethasone—atopic dermatitis	5.14e-05	0.00036	CcSEcCtD
Eletriptan—Urticaria—Hydrocortisone—atopic dermatitis	5.11e-05	0.000358	CcSEcCtD
Eletriptan—Abdominal pain—Hydrocortisone—atopic dermatitis	5.09e-05	0.000357	CcSEcCtD
Eletriptan—Body temperature increased—Hydrocortisone—atopic dermatitis	5.09e-05	0.000357	CcSEcCtD
Eletriptan—Convulsion—Prednisone—atopic dermatitis	5.08e-05	0.000356	CcSEcCtD
Eletriptan—Hypertension—Prednisone—atopic dermatitis	5.07e-05	0.000355	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	5.01e-05	0.000351	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	5.01e-05	0.000351	CcSEcCtD
Eletriptan—Arthralgia—Prednisone—atopic dermatitis	5e-05	0.00035	CcSEcCtD
Eletriptan—Myalgia—Prednisone—atopic dermatitis	5e-05	0.00035	CcSEcCtD
Eletriptan—Feeling abnormal—Triamcinolone—atopic dermatitis	4.99e-05	0.00035	CcSEcCtD
Eletriptan—Feeling abnormal—Methylprednisolone—atopic dermatitis	4.98e-05	0.000349	CcSEcCtD
Eletriptan—Anxiety—Prednisone—atopic dermatitis	4.98e-05	0.000349	CcSEcCtD
Eletriptan—Insomnia—Dexamethasone—atopic dermatitis	4.97e-05	0.000349	CcSEcCtD
Eletriptan—Insomnia—Betamethasone—atopic dermatitis	4.97e-05	0.000349	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	4.96e-05	0.000348	CcSEcCtD
Eletriptan—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	4.94e-05	0.000346	CcSEcCtD
Eletriptan—Paraesthesia—Dexamethasone—atopic dermatitis	4.94e-05	0.000346	CcSEcCtD
Eletriptan—Paraesthesia—Betamethasone—atopic dermatitis	4.94e-05	0.000346	CcSEcCtD
Eletriptan—Discomfort—Prednisone—atopic dermatitis	4.94e-05	0.000346	CcSEcCtD
Eletriptan—Hypersensitivity—Prednisolone—atopic dermatitis	4.86e-05	0.00034	CcSEcCtD
Eletriptan—Dyspepsia—Dexamethasone—atopic dermatitis	4.84e-05	0.000339	CcSEcCtD
Eletriptan—Dyspepsia—Betamethasone—atopic dermatitis	4.84e-05	0.000339	CcSEcCtD
Eletriptan—Urticaria—Triamcinolone—atopic dermatitis	4.81e-05	0.000337	CcSEcCtD
Eletriptan—Urticaria—Methylprednisolone—atopic dermatitis	4.8e-05	0.000337	CcSEcCtD
Eletriptan—Body temperature increased—Triamcinolone—atopic dermatitis	4.79e-05	0.000336	CcSEcCtD
Eletriptan—Oedema—Prednisone—atopic dermatitis	4.79e-05	0.000336	CcSEcCtD
Eletriptan—Abdominal pain—Methylprednisolone—atopic dermatitis	4.78e-05	0.000335	CcSEcCtD
Eletriptan—Decreased appetite—Betamethasone—atopic dermatitis	4.78e-05	0.000335	CcSEcCtD
Eletriptan—Decreased appetite—Dexamethasone—atopic dermatitis	4.78e-05	0.000335	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Betamethasone—atopic dermatitis	4.75e-05	0.000333	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	4.75e-05	0.000333	CcSEcCtD
Eletriptan—Hypersensitivity—Hydrocortisone—atopic dermatitis	4.74e-05	0.000332	CcSEcCtD
Eletriptan—Fatigue—Dexamethasone—atopic dermatitis	4.74e-05	0.000332	CcSEcCtD
Eletriptan—Fatigue—Betamethasone—atopic dermatitis	4.74e-05	0.000332	CcSEcCtD
Eletriptan—Shock—Prednisone—atopic dermatitis	4.71e-05	0.00033	CcSEcCtD
Eletriptan—Pain—Betamethasone—atopic dermatitis	4.7e-05	0.00033	CcSEcCtD
Eletriptan—Pain—Dexamethasone—atopic dermatitis	4.7e-05	0.00033	CcSEcCtD
Eletriptan—Nervous system disorder—Prednisone—atopic dermatitis	4.7e-05	0.000329	CcSEcCtD
Eletriptan—Tachycardia—Prednisone—atopic dermatitis	4.67e-05	0.000328	CcSEcCtD
Eletriptan—Skin disorder—Prednisone—atopic dermatitis	4.65e-05	0.000326	CcSEcCtD
Eletriptan—Hyperhidrosis—Prednisone—atopic dermatitis	4.63e-05	0.000324	CcSEcCtD
Eletriptan—Asthenia—Hydrocortisone—atopic dermatitis	4.62e-05	0.000324	CcSEcCtD
Eletriptan—Anorexia—Prednisone—atopic dermatitis	4.56e-05	0.00032	CcSEcCtD
Eletriptan—Pruritus—Hydrocortisone—atopic dermatitis	4.55e-05	0.000319	CcSEcCtD
Eletriptan—Feeling abnormal—Dexamethasone—atopic dermatitis	4.53e-05	0.000318	CcSEcCtD
Eletriptan—Feeling abnormal—Betamethasone—atopic dermatitis	4.53e-05	0.000318	CcSEcCtD
Eletriptan—Gastrointestinal pain—Dexamethasone—atopic dermatitis	4.5e-05	0.000315	CcSEcCtD
Eletriptan—Gastrointestinal pain—Betamethasone—atopic dermatitis	4.5e-05	0.000315	CcSEcCtD
Eletriptan—Hypersensitivity—Triamcinolone—atopic dermatitis	4.46e-05	0.000313	CcSEcCtD
Eletriptan—Hypersensitivity—Methylprednisolone—atopic dermatitis	4.46e-05	0.000312	CcSEcCtD
Eletriptan—Diarrhoea—Hydrocortisone—atopic dermatitis	4.4e-05	0.000309	CcSEcCtD
Eletriptan—Urticaria—Betamethasone—atopic dermatitis	4.37e-05	0.000306	CcSEcCtD
Eletriptan—Urticaria—Dexamethasone—atopic dermatitis	4.37e-05	0.000306	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Prednisone—atopic dermatitis	4.36e-05	0.000306	CcSEcCtD
Eletriptan—Dizziness—Prednisolone—atopic dermatitis	4.36e-05	0.000305	CcSEcCtD
Eletriptan—Asthenia—Triamcinolone—atopic dermatitis	4.35e-05	0.000305	CcSEcCtD
Eletriptan—Abdominal pain—Betamethasone—atopic dermatitis	4.35e-05	0.000305	CcSEcCtD
Eletriptan—Body temperature increased—Dexamethasone—atopic dermatitis	4.35e-05	0.000305	CcSEcCtD
Eletriptan—Abdominal pain—Dexamethasone—atopic dermatitis	4.35e-05	0.000305	CcSEcCtD
Eletriptan—Body temperature increased—Betamethasone—atopic dermatitis	4.35e-05	0.000305	CcSEcCtD
Eletriptan—Asthenia—Methylprednisolone—atopic dermatitis	4.34e-05	0.000304	CcSEcCtD
Eletriptan—Insomnia—Prednisone—atopic dermatitis	4.33e-05	0.000304	CcSEcCtD
Eletriptan—Paraesthesia—Prednisone—atopic dermatitis	4.3e-05	0.000301	CcSEcCtD
Eletriptan—Pruritus—Triamcinolone—atopic dermatitis	4.29e-05	0.0003	CcSEcCtD
Eletriptan—Pruritus—Methylprednisolone—atopic dermatitis	4.28e-05	0.0003	CcSEcCtD
Eletriptan—Dizziness—Hydrocortisone—atopic dermatitis	4.26e-05	0.000298	CcSEcCtD
Eletriptan—Dyspepsia—Prednisone—atopic dermatitis	4.22e-05	0.000295	CcSEcCtD
Eletriptan—Decreased appetite—Prednisone—atopic dermatitis	4.16e-05	0.000292	CcSEcCtD
Eletriptan—Rash—Prednisolone—atopic dermatitis	4.16e-05	0.000291	CcSEcCtD
Eletriptan—Dermatitis—Prednisolone—atopic dermatitis	4.15e-05	0.000291	CcSEcCtD
Eletriptan—Diarrhoea—Methylprednisolone—atopic dermatitis	4.14e-05	0.00029	CcSEcCtD
Eletriptan—Fatigue—Prednisone—atopic dermatitis	4.13e-05	0.000289	CcSEcCtD
Eletriptan—Headache—Prednisolone—atopic dermatitis	4.13e-05	0.000289	CcSEcCtD
Eletriptan—Constipation—Prednisone—atopic dermatitis	4.1e-05	0.000287	CcSEcCtD
Eletriptan—Vomiting—Hydrocortisone—atopic dermatitis	4.09e-05	0.000287	CcSEcCtD
Eletriptan—Rash—Hydrocortisone—atopic dermatitis	4.06e-05	0.000284	CcSEcCtD
Eletriptan—Dermatitis—Hydrocortisone—atopic dermatitis	4.05e-05	0.000284	CcSEcCtD
Eletriptan—Headache—Hydrocortisone—atopic dermatitis	4.03e-05	0.000283	CcSEcCtD
Eletriptan—Dizziness—Triamcinolone—atopic dermatitis	4.01e-05	0.000281	CcSEcCtD
Eletriptan—Dizziness—Methylprednisolone—atopic dermatitis	4e-05	0.00028	CcSEcCtD
Eletriptan—Feeling abnormal—Prednisone—atopic dermatitis	3.95e-05	0.000277	CcSEcCtD
Eletriptan—Asthenia—Betamethasone—atopic dermatitis	3.95e-05	0.000276	CcSEcCtD
Eletriptan—Asthenia—Dexamethasone—atopic dermatitis	3.95e-05	0.000276	CcSEcCtD
Eletriptan—Gastrointestinal pain—Prednisone—atopic dermatitis	3.92e-05	0.000274	CcSEcCtD
Eletriptan—Nausea—Prednisolone—atopic dermatitis	3.91e-05	0.000274	CcSEcCtD
Eletriptan—Pruritus—Betamethasone—atopic dermatitis	3.89e-05	0.000273	CcSEcCtD
Eletriptan—Pruritus—Dexamethasone—atopic dermatitis	3.89e-05	0.000273	CcSEcCtD
Eletriptan—Vomiting—Triamcinolone—atopic dermatitis	3.85e-05	0.00027	CcSEcCtD
Eletriptan—Vomiting—Methylprednisolone—atopic dermatitis	3.84e-05	0.000269	CcSEcCtD
Eletriptan—Nausea—Hydrocortisone—atopic dermatitis	3.82e-05	0.000268	CcSEcCtD
Eletriptan—Rash—Triamcinolone—atopic dermatitis	3.82e-05	0.000268	CcSEcCtD
Eletriptan—Dermatitis—Triamcinolone—atopic dermatitis	3.82e-05	0.000268	CcSEcCtD
Eletriptan—Rash—Methylprednisolone—atopic dermatitis	3.81e-05	0.000267	CcSEcCtD
Eletriptan—Dermatitis—Methylprednisolone—atopic dermatitis	3.81e-05	0.000267	CcSEcCtD
Eletriptan—Urticaria—Prednisone—atopic dermatitis	3.8e-05	0.000267	CcSEcCtD
Eletriptan—Headache—Triamcinolone—atopic dermatitis	3.8e-05	0.000266	CcSEcCtD
Eletriptan—Headache—Methylprednisolone—atopic dermatitis	3.79e-05	0.000265	CcSEcCtD
Eletriptan—Abdominal pain—Prednisone—atopic dermatitis	3.79e-05	0.000265	CcSEcCtD
Eletriptan—Body temperature increased—Prednisone—atopic dermatitis	3.79e-05	0.000265	CcSEcCtD
Eletriptan—Diarrhoea—Betamethasone—atopic dermatitis	3.76e-05	0.000264	CcSEcCtD
Eletriptan—Diarrhoea—Dexamethasone—atopic dermatitis	3.76e-05	0.000264	CcSEcCtD
Eletriptan—Dizziness—Dexamethasone—atopic dermatitis	3.64e-05	0.000255	CcSEcCtD
Eletriptan—Dizziness—Betamethasone—atopic dermatitis	3.64e-05	0.000255	CcSEcCtD
Eletriptan—Nausea—Triamcinolone—atopic dermatitis	3.6e-05	0.000252	CcSEcCtD
Eletriptan—Nausea—Methylprednisolone—atopic dermatitis	3.59e-05	0.000252	CcSEcCtD
Eletriptan—Hypersensitivity—Prednisone—atopic dermatitis	3.53e-05	0.000247	CcSEcCtD
Eletriptan—Vomiting—Dexamethasone—atopic dermatitis	3.5e-05	0.000245	CcSEcCtD
Eletriptan—Vomiting—Betamethasone—atopic dermatitis	3.5e-05	0.000245	CcSEcCtD
Eletriptan—Rash—Betamethasone—atopic dermatitis	3.47e-05	0.000243	CcSEcCtD
Eletriptan—Rash—Dexamethasone—atopic dermatitis	3.47e-05	0.000243	CcSEcCtD
Eletriptan—Dermatitis—Betamethasone—atopic dermatitis	3.46e-05	0.000243	CcSEcCtD
Eletriptan—Dermatitis—Dexamethasone—atopic dermatitis	3.46e-05	0.000243	CcSEcCtD
Eletriptan—Headache—Dexamethasone—atopic dermatitis	3.44e-05	0.000241	CcSEcCtD
Eletriptan—Headache—Betamethasone—atopic dermatitis	3.44e-05	0.000241	CcSEcCtD
Eletriptan—Asthenia—Prednisone—atopic dermatitis	3.44e-05	0.000241	CcSEcCtD
Eletriptan—Pruritus—Prednisone—atopic dermatitis	3.39e-05	0.000237	CcSEcCtD
Eletriptan—Diarrhoea—Prednisone—atopic dermatitis	3.28e-05	0.00023	CcSEcCtD
Eletriptan—Nausea—Dexamethasone—atopic dermatitis	3.27e-05	0.000229	CcSEcCtD
Eletriptan—Nausea—Betamethasone—atopic dermatitis	3.27e-05	0.000229	CcSEcCtD
Eletriptan—Dizziness—Prednisone—atopic dermatitis	3.17e-05	0.000222	CcSEcCtD
Eletriptan—Vomiting—Prednisone—atopic dermatitis	3.04e-05	0.000213	CcSEcCtD
Eletriptan—Rash—Prednisone—atopic dermatitis	3.02e-05	0.000212	CcSEcCtD
Eletriptan—Dermatitis—Prednisone—atopic dermatitis	3.02e-05	0.000211	CcSEcCtD
Eletriptan—Headache—Prednisone—atopic dermatitis	3e-05	0.00021	CcSEcCtD
Eletriptan—Nausea—Prednisone—atopic dermatitis	2.84e-05	0.000199	CcSEcCtD
Eletriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.44e-05	0.000841	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—IL5—atopic dermatitis	2.41e-05	0.000832	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCL22—atopic dermatitis	2.41e-05	0.000832	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL5—atopic dermatitis	2.4e-05	0.000827	CbGpPWpGaD
Eletriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.39e-05	0.000823	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL5—atopic dermatitis	2.38e-05	0.000822	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCL17—atopic dermatitis	2.38e-05	0.00082	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GLB1—atopic dermatitis	2.37e-05	0.000817	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TAC1—atopic dermatitis	2.37e-05	0.000817	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—NPS—atopic dermatitis	2.37e-05	0.000817	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—CCR3—atopic dermatitis	2.36e-05	0.000815	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—NPS—atopic dermatitis	2.36e-05	0.000813	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—TAC1—atopic dermatitis	2.36e-05	0.000813	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL5—atopic dermatitis	2.33e-05	0.000805	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—CCR5—atopic dermatitis	2.32e-05	0.000802	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CXCR3—atopic dermatitis	2.32e-05	0.000801	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—KIF3A—atopic dermatitis	2.32e-05	0.0008	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—CXCR3—atopic dermatitis	2.31e-05	0.000797	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—KIF3A—atopic dermatitis	2.3e-05	0.000795	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—CCR5—atopic dermatitis	2.29e-05	0.00079	CbGpPWpGaD
Eletriptan—HTR1A—G alpha (i) signalling events—CXCL8—atopic dermatitis	2.29e-05	0.000789	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ADSL—atopic dermatitis	2.27e-05	0.000783	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—KIF3A—atopic dermatitis	2.26e-05	0.000778	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—CXCL10—atopic dermatitis	2.25e-05	0.000777	CbGpPWpGaD
Eletriptan—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.24e-05	0.000773	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GLB1—atopic dermatitis	2.24e-05	0.000773	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—CXCL10—atopic dermatitis	2.24e-05	0.000772	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TAC1—atopic dermatitis	2.23e-05	0.00077	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—NPS—atopic dermatitis	2.23e-05	0.00077	CbGpPWpGaD
Eletriptan—HTR1A—SIDS Susceptibility Pathways—TNF—atopic dermatitis	2.21e-05	0.000762	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL5—atopic dermatitis	2.2e-05	0.000759	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL5—atopic dermatitis	2.19e-05	0.000756	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—CXCL10—atopic dermatitis	2.19e-05	0.000756	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CXCR3—atopic dermatitis	2.19e-05	0.000755	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCL27—atopic dermatitis	2.15e-05	0.000742	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ADSL—atopic dermatitis	2.15e-05	0.000741	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CCR3—atopic dermatitis	2.15e-05	0.00074	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—KIF3A—atopic dermatitis	2.12e-05	0.000731	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—NPS—atopic dermatitis	2.11e-05	0.000726	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—TAC1—atopic dermatitis	2.11e-05	0.000726	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CMA1—atopic dermatitis	2.1e-05	0.000723	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CCL11—atopic dermatitis	2.1e-05	0.000723	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CCL11—atopic dermatitis	2.08e-05	0.000719	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CMA1—atopic dermatitis	2.08e-05	0.000719	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL5—atopic dermatitis	2.08e-05	0.000716	CbGpPWpGaD
Eletriptan—ABCB1—Allograft Rejection—TNF—atopic dermatitis	2.07e-05	0.000714	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—CXCR3—atopic dermatitis	2.07e-05	0.000712	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—CXCL10—atopic dermatitis	2.06e-05	0.00071	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	2.06e-05	0.00071	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—CXCL10—atopic dermatitis	2.05e-05	0.000705	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CCL11—atopic dermatitis	2.04e-05	0.000704	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CMA1—atopic dermatitis	2.04e-05	0.000704	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—CXCL10—atopic dermatitis	2.03e-05	0.000701	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—CXCL10—atopic dermatitis	1.99e-05	0.000686	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—STAT6—atopic dermatitis	1.97e-05	0.00068	CbGpPWpGaD
Eletriptan—HTR7—Circadian rythm related genes—IL6—atopic dermatitis	1.96e-05	0.000678	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—STAT6—atopic dermatitis	1.96e-05	0.000676	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—IL5—atopic dermatitis	1.96e-05	0.000675	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—CCL5—atopic dermatitis	1.94e-05	0.000669	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCL17—atopic dermatitis	1.93e-05	0.000665	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—CCL5—atopic dermatitis	1.93e-05	0.000664	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—STAT6—atopic dermatitis	1.92e-05	0.000662	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCL11—atopic dermatitis	1.92e-05	0.000661	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CMA1—atopic dermatitis	1.92e-05	0.000661	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—TAC1—atopic dermatitis	1.91e-05	0.000659	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—NPS—atopic dermatitis	1.91e-05	0.000659	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	1.91e-05	0.000658	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—CCL5—atopic dermatitis	1.89e-05	0.00065	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CXCL10—atopic dermatitis	1.88e-05	0.000647	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CXCR3—atopic dermatitis	1.88e-05	0.000647	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—CXCL10—atopic dermatitis	1.87e-05	0.000645	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—CXCL8—atopic dermatitis	1.87e-05	0.000644	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—CXCL8—atopic dermatitis	1.86e-05	0.00064	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	1.86e-05	0.00064	CbGpPWpGaD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.82e-05	0.000627	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—CXCL8—atopic dermatitis	1.82e-05	0.000627	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—STAT6—atopic dermatitis	1.8e-05	0.000622	CbGpPWpGaD
Eletriptan—HTR1A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.78e-05	0.000615	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL5—atopic dermatitis	1.78e-05	0.000613	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—CCL5—atopic dermatitis	1.77e-05	0.000611	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CXCL10—atopic dermatitis	1.77e-05	0.000611	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—CCL5—atopic dermatitis	1.76e-05	0.000607	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—CCL5—atopic dermatitis	1.75e-05	0.000603	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—CCR5—atopic dermatitis	1.75e-05	0.000602	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—CCR5—atopic dermatitis	1.74e-05	0.000598	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.73e-05	0.000595	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—KIF3A—atopic dermatitis	1.72e-05	0.000593	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—CCL5—atopic dermatitis	1.71e-05	0.000591	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CCR3—atopic dermatitis	1.71e-05	0.00059	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—CXCL8—atopic dermatitis	1.71e-05	0.000589	CbGpPWpGaD
Eletriptan—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.7e-05	0.000587	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—CCR5—atopic dermatitis	1.7e-05	0.000586	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CCR3—atopic dermatitis	1.7e-05	0.000586	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—CXCL10—atopic dermatitis	1.67e-05	0.000576	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CCR3—atopic dermatitis	1.66e-05	0.000574	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—CXCL8—atopic dermatitis	1.64e-05	0.000566	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CCL5—atopic dermatitis	1.62e-05	0.000557	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—CCL5—atopic dermatitis	1.61e-05	0.000555	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—CCR5—atopic dermatitis	1.6e-05	0.00055	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—CCR5—atopic dermatitis	1.59e-05	0.000547	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—CCR5—atopic dermatitis	1.58e-05	0.000543	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—IL2—atopic dermatitis	1.57e-05	0.000541	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCR3—atopic dermatitis	1.56e-05	0.000539	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CMA1—atopic dermatitis	1.55e-05	0.000536	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCL11—atopic dermatitis	1.55e-05	0.000536	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—CXCL8—atopic dermatitis	1.55e-05	0.000534	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—CCR5—atopic dermatitis	1.54e-05	0.000532	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CCL5—atopic dermatitis	1.52e-05	0.000526	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NPS—atopic dermatitis	1.52e-05	0.000526	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TAC1—atopic dermatitis	1.52e-05	0.000526	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CXCL10—atopic dermatitis	1.52e-05	0.000523	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TAC1—atopic dermatitis	1.51e-05	0.000522	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NPS—atopic dermatitis	1.51e-05	0.000522	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—NGF—atopic dermatitis	1.5e-05	0.000516	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CXCR3—atopic dermatitis	1.49e-05	0.000515	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—CXCL8—atopic dermatitis	1.49e-05	0.000514	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CXCR3—atopic dermatitis	1.49e-05	0.000512	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TAC1—atopic dermatitis	1.48e-05	0.000511	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NPS—atopic dermatitis	1.48e-05	0.000511	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—IL2—atopic dermatitis	1.48e-05	0.00051	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—STAT6—atopic dermatitis	1.46e-05	0.000504	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CCR5—atopic dermatitis	1.46e-05	0.000502	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CXCR3—atopic dermatitis	1.45e-05	0.000501	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—CCR5—atopic dermatitis	1.45e-05	0.0005	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—CCL5—atopic dermatitis	1.44e-05	0.000495	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—IL2—atopic dermatitis	1.42e-05	0.000491	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL5—atopic dermatitis	1.42e-05	0.000489	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—NGF—atopic dermatitis	1.41e-05	0.000487	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL5—atopic dermatitis	1.41e-05	0.000485	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—CXCL8—atopic dermatitis	1.41e-05	0.000485	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NPS—atopic dermatitis	1.39e-05	0.00048	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TAC1—atopic dermatitis	1.39e-05	0.00048	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—CXCL8—atopic dermatitis	1.38e-05	0.000478	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL5—atopic dermatitis	1.38e-05	0.000475	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CCR5—atopic dermatitis	1.37e-05	0.000474	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GLB1—atopic dermatitis	1.37e-05	0.000471	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CXCR3—atopic dermatitis	1.37e-05	0.000471	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—IL2—atopic dermatitis	1.34e-05	0.000463	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GLB1—atopic dermatitis	1.33e-05	0.00046	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ADSL—atopic dermatitis	1.31e-05	0.000452	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CCL5—atopic dermatitis	1.3e-05	0.00045	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL5—atopic dermatitis	1.29e-05	0.000447	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—CCR5—atopic dermatitis	1.29e-05	0.000446	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.29e-05	0.000445	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ADSL—atopic dermatitis	1.28e-05	0.000441	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCR3—atopic dermatitis	1.27e-05	0.000437	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GLB1—atopic dermatitis	1.26e-05	0.000433	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GLB1—atopic dermatitis	1.25e-05	0.00043	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—NFKBIA—atopic dermatitis	1.23e-05	0.000426	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CXCL10—atopic dermatitis	1.21e-05	0.000417	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ADSL—atopic dermatitis	1.2e-05	0.000415	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CXCL10—atopic dermatitis	1.2e-05	0.000414	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ADSL—atopic dermatitis	1.19e-05	0.000412	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CCR5—atopic dermatitis	1.18e-05	0.000405	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CXCL10—atopic dermatitis	1.18e-05	0.000405	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—NFKBIA—atopic dermatitis	1.16e-05	0.000401	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TAC1—atopic dermatitis	1.13e-05	0.00039	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NPS—atopic dermatitis	1.13e-05	0.00039	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CXCR3—atopic dermatitis	1.11e-05	0.000382	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CXCL10—atopic dermatitis	1.1e-05	0.000381	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—CXCL8—atopic dermatitis	1.06e-05	0.000364	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL5—atopic dermatitis	1.05e-05	0.000362	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—CXCL8—atopic dermatitis	1.05e-05	0.000362	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CCL5—atopic dermatitis	1.04e-05	0.000359	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CCL5—atopic dermatitis	1.03e-05	0.000356	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.03e-05	0.000354	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.02e-05	0.000352	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CCL5—atopic dermatitis	1.01e-05	0.000349	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—IL2—atopic dermatitis	1.01e-05	0.000348	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—IL2—atopic dermatitis	1e-05	0.000346	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	9.95e-06	0.000343	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—IL2—atopic dermatitis	9.82e-06	0.000339	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—CXCL8—atopic dermatitis	9.65e-06	0.000333	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NGF—atopic dermatitis	9.63e-06	0.000332	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—CXCL8—atopic dermatitis	9.59e-06	0.000331	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NGF—atopic dermatitis	9.57e-06	0.00033	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—CXCL8—atopic dermatitis	9.53e-06	0.000329	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCL5—atopic dermatitis	9.5e-06	0.000328	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NGF—atopic dermatitis	9.37e-06	0.000323	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CCR5—atopic dermatitis	9.37e-06	0.000323	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—CXCL8—atopic dermatitis	9.33e-06	0.000322	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CCR5—atopic dermatitis	9.31e-06	0.000321	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	9.24e-06	0.000319	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—IL2—atopic dermatitis	9.22e-06	0.000318	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL2—atopic dermatitis	9.17e-06	0.000316	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	9.12e-06	0.000314	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL2—atopic dermatitis	9.11e-06	0.000314	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	9.08e-06	0.000313	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	8.95e-06	0.000309	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	8.92e-06	0.000307	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NGF—atopic dermatitis	8.8e-06	0.000304	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CXCL8—atopic dermatitis	8.8e-06	0.000304	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—CXCL8—atopic dermatitis	8.76e-06	0.000302	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCR5—atopic dermatitis	8.56e-06	0.000295	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL2—atopic dermatitis	8.41e-06	0.00029	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL2—atopic dermatitis	8.38e-06	0.000289	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—IL6—atopic dermatitis	8.37e-06	0.000289	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CXCL8—atopic dermatitis	8.3e-06	0.000286	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GLB1—atopic dermatitis	8.21e-06	0.000283	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NFKBIA—atopic dermatitis	7.94e-06	0.000274	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL2—atopic dermatitis	7.93e-06	0.000274	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—IL6—atopic dermatitis	7.9e-06	0.000272	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	7.89e-06	0.000272	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ADSL—atopic dermatitis	7.88e-06	0.000272	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	7.83e-06	0.00027	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MAPK8—atopic dermatitis	7.74e-06	0.000267	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	7.73e-06	0.000266	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	7.71e-06	0.000266	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PPARA—atopic dermatitis	7.69e-06	0.000265	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	7.48e-06	0.000258	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MAPK8—atopic dermatitis	7.3e-06	0.000252	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PPARA—atopic dermatitis	7.27e-06	0.000251	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NFKBIA—atopic dermatitis	7.26e-06	0.00025	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NGF—atopic dermatitis	7.14e-06	0.000246	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	7.11e-06	0.000245	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	6.94e-06	0.000239	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	6.79e-06	0.000234	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	5.89e-06	0.000203	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CXCL8—atopic dermatitis	5.67e-06	0.000195	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	5.63e-06	0.000194	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	5.51e-06	0.00019	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL2—atopic dermatitis	5.41e-06	0.000187	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL6—atopic dermatitis	5.39e-06	0.000186	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL2—atopic dermatitis	5.38e-06	0.000185	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	5.35e-06	0.000185	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL2—atopic dermatitis	5.27e-06	0.000182	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	5.24e-06	0.000181	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CXCL8—atopic dermatitis	5.18e-06	0.000179	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MAPK8—atopic dermatitis	4.98e-06	0.000172	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	4.95e-06	0.000171	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL2—atopic dermatitis	4.95e-06	0.000171	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL6—atopic dermatitis	4.94e-06	0.00017	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL6—atopic dermatitis	4.92e-06	0.00017	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	4.85e-06	0.000167	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL6—atopic dermatitis	4.66e-06	0.000161	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MAPK8—atopic dermatitis	4.55e-06	0.000157	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PPARA—atopic dermatitis	4.43e-06	0.000153	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PPARA—atopic dermatitis	4.33e-06	0.000149	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	4.2e-06	0.000145	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PPARA—atopic dermatitis	4.08e-06	0.000141	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PPARA—atopic dermatitis	4.04e-06	0.000139	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL2—atopic dermatitis	4.01e-06	0.000138	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	3.99e-06	0.000138	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	3.69e-06	0.000127	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL6—atopic dermatitis	3.18e-06	0.00011	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL6—atopic dermatitis	3.16e-06	0.000109	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL6—atopic dermatitis	3.1e-06	0.000107	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL6—atopic dermatitis	2.91e-06	0.0001	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PPARA—atopic dermatitis	2.67e-06	9.19e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL6—atopic dermatitis	2.36e-06	8.13e-05	CbGpPWpGaD
